ADVANCED SOLID CANCER
Clinical trials for ADVANCED SOLID CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID CANCER trials appear
Sign up with your email to follow new studies for ADVANCED SOLID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to shrink hard-to-treat cancers
Disease control Recruiting nowThis early-stage study tests a new drug called APX-343A, given alone or with an immunotherapy (pembrolizumab), in people with advanced solid tumors that have not responded to other treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink …
Matched conditions: ADVANCED SOLID CANCER
Phase: PHASE1 • Sponsor: Aptabio Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 09:07 UTC
-
New drug targets Hard-to-Treat cancers by breaking down mutant protein
Disease control Recruiting nowThis study tests a new drug called ARV-806 in adults with advanced solid tumors that have a specific KRAS G12D mutation. The drug aims to break down the faulty protein that helps tumors grow. The study has two parts: first, finding safe doses in small groups, then testing the bes…
Matched conditions: ADVANCED SOLID CANCER
Phase: PHASE1, PHASE2 • Sponsor: Arvinas Inc. • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New hope for advanced cancer: first human trial of SIM0609 begins
Disease control Recruiting nowThis early-stage study is testing a new drug, SIM0609, in adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety and find the right dose. About 232 participants will take part in this first-in-human trial.
Matched conditions: ADVANCED SOLID CANCER
Phase: PHASE1 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New hope for advanced cancer: MHB046C injection enters human trials
Disease control Recruiting nowThis study tests a new drug called MHB046C in 200 adults with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. Participants receive the drug by IV and are closely monitored for side effect…
Matched conditions: ADVANCED SOLID CANCER
Phase: PHASE1, PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated May 19, 2026 12:01 UTC